Cargando…
The impact of urine microbiota in patients with lower urinary tract symptoms
INTRODUCTION: Inflammation and infection are causative factors of benign prostatic hyperplasia (BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an important role in the development of BPH and can influence the severity of lower urinary tract symptoms (LUTS). MA...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051042/ https://www.ncbi.nlm.nih.gov/pubmed/33858430 http://dx.doi.org/10.1186/s12941-021-00428-9 |
_version_ | 1783679686176407552 |
---|---|
author | Lee, Hsiang-Ying Wang, Jiunn‐Wei Juan, Yung-Shun Li, Ching-Chia Liu, Chung-Jung Cho, Sung Yong Yeh, Hsin-Chih Chueh, Kuang-Shun Wu, Wen-Jeng Wu, Deng‐Chyang |
author_facet | Lee, Hsiang-Ying Wang, Jiunn‐Wei Juan, Yung-Shun Li, Ching-Chia Liu, Chung-Jung Cho, Sung Yong Yeh, Hsin-Chih Chueh, Kuang-Shun Wu, Wen-Jeng Wu, Deng‐Chyang |
author_sort | Lee, Hsiang-Ying |
collection | PubMed |
description | INTRODUCTION: Inflammation and infection are causative factors of benign prostatic hyperplasia (BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an important role in the development of BPH and can influence the severity of lower urinary tract symptoms (LUTS). MATERIALS AND METHODS: We collected mid-stream voided urine samples from BPH patients and control participants and stored them in a freezer at − 80 °C. All enrolled participants were requested to provide information about their clinical characteristics and complete the International Prostate Symptom Score (IPSS) questionnaire. Each step of the procedure, including the extraction of the genomic DNA from the urine samples; the amplification by polymerase chain reaction (PCR); PCR product quantification, mixing, and purification; DNA library preparation; and sequencing was performed with quality control (QC) measures. Alpha diversity was indicative of the species complexity within individual urine samples, and beta diversity analysis was used to evaluate the differences among the samples in terms of species complexity. Pearson’s correlation analysis was performed to calculate the relationship between the clinical characteristics of the participants and the microbiota species in the urine samples. RESULTS: We enrolled 77 BPH patients and 30 control participants who reported no recent antibiotic usage. Old age, high IPSS and poor quality of life were observed in the participants of the BPH group. No significant differences were observed in the alpha diversity of the samples. In the beta diversity analysis, there was a significant difference between the microbiota in the samples of the BPH and control groups according to ANOSIM statistical analysis. On comparing the groups, the ten bacterial genera present in the samples of the BPH group in descending order of abundance were: Sphingomonas, Bacteroides, Lactobacillus, Streptococcus, Alcaligenes, Prevotella, Ruminococcaceae UCG-014, Escherichia_Shigella, Akkermansia, and Parabacteroides. Spearman’s correlation analysis revealed that urine samples showing the presence of the bacterial genera Haemophilus, Staphylococcus, Dolosigranulum, Listeria, Phascolarctobacterium, Enhydrobacter, Bacillus, [Ruminococcus]torques, Faecalibacterium, and Finegoldia correlated with a high IPSS, and severe storage and voiding symptoms (P < 0.05). CONCLUSION: Our current study shows that dysbiosis of urine microbiota may be related to the development of BPH and the severity of LUTS. Further research targeting specific microbes to identify their role in the development of diseases is necessary and might provide novel diagnostic biomarkers and therapeutic options. |
format | Online Article Text |
id | pubmed-8051042 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80510422021-04-19 The impact of urine microbiota in patients with lower urinary tract symptoms Lee, Hsiang-Ying Wang, Jiunn‐Wei Juan, Yung-Shun Li, Ching-Chia Liu, Chung-Jung Cho, Sung Yong Yeh, Hsin-Chih Chueh, Kuang-Shun Wu, Wen-Jeng Wu, Deng‐Chyang Ann Clin Microbiol Antimicrob Research INTRODUCTION: Inflammation and infection are causative factors of benign prostatic hyperplasia (BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an important role in the development of BPH and can influence the severity of lower urinary tract symptoms (LUTS). MATERIALS AND METHODS: We collected mid-stream voided urine samples from BPH patients and control participants and stored them in a freezer at − 80 °C. All enrolled participants were requested to provide information about their clinical characteristics and complete the International Prostate Symptom Score (IPSS) questionnaire. Each step of the procedure, including the extraction of the genomic DNA from the urine samples; the amplification by polymerase chain reaction (PCR); PCR product quantification, mixing, and purification; DNA library preparation; and sequencing was performed with quality control (QC) measures. Alpha diversity was indicative of the species complexity within individual urine samples, and beta diversity analysis was used to evaluate the differences among the samples in terms of species complexity. Pearson’s correlation analysis was performed to calculate the relationship between the clinical characteristics of the participants and the microbiota species in the urine samples. RESULTS: We enrolled 77 BPH patients and 30 control participants who reported no recent antibiotic usage. Old age, high IPSS and poor quality of life were observed in the participants of the BPH group. No significant differences were observed in the alpha diversity of the samples. In the beta diversity analysis, there was a significant difference between the microbiota in the samples of the BPH and control groups according to ANOSIM statistical analysis. On comparing the groups, the ten bacterial genera present in the samples of the BPH group in descending order of abundance were: Sphingomonas, Bacteroides, Lactobacillus, Streptococcus, Alcaligenes, Prevotella, Ruminococcaceae UCG-014, Escherichia_Shigella, Akkermansia, and Parabacteroides. Spearman’s correlation analysis revealed that urine samples showing the presence of the bacterial genera Haemophilus, Staphylococcus, Dolosigranulum, Listeria, Phascolarctobacterium, Enhydrobacter, Bacillus, [Ruminococcus]torques, Faecalibacterium, and Finegoldia correlated with a high IPSS, and severe storage and voiding symptoms (P < 0.05). CONCLUSION: Our current study shows that dysbiosis of urine microbiota may be related to the development of BPH and the severity of LUTS. Further research targeting specific microbes to identify their role in the development of diseases is necessary and might provide novel diagnostic biomarkers and therapeutic options. BioMed Central 2021-04-15 /pmc/articles/PMC8051042/ /pubmed/33858430 http://dx.doi.org/10.1186/s12941-021-00428-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lee, Hsiang-Ying Wang, Jiunn‐Wei Juan, Yung-Shun Li, Ching-Chia Liu, Chung-Jung Cho, Sung Yong Yeh, Hsin-Chih Chueh, Kuang-Shun Wu, Wen-Jeng Wu, Deng‐Chyang The impact of urine microbiota in patients with lower urinary tract symptoms |
title | The impact of urine microbiota in patients with lower urinary tract symptoms |
title_full | The impact of urine microbiota in patients with lower urinary tract symptoms |
title_fullStr | The impact of urine microbiota in patients with lower urinary tract symptoms |
title_full_unstemmed | The impact of urine microbiota in patients with lower urinary tract symptoms |
title_short | The impact of urine microbiota in patients with lower urinary tract symptoms |
title_sort | impact of urine microbiota in patients with lower urinary tract symptoms |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051042/ https://www.ncbi.nlm.nih.gov/pubmed/33858430 http://dx.doi.org/10.1186/s12941-021-00428-9 |
work_keys_str_mv | AT leehsiangying theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT wangjiunnwei theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT juanyungshun theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT lichingchia theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT liuchungjung theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT chosungyong theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT yehhsinchih theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT chuehkuangshun theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT wuwenjeng theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT wudengchyang theimpactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT leehsiangying impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT wangjiunnwei impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT juanyungshun impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT lichingchia impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT liuchungjung impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT chosungyong impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT yehhsinchih impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT chuehkuangshun impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT wuwenjeng impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms AT wudengchyang impactofurinemicrobiotainpatientswithlowerurinarytractsymptoms |